Copper Cu 64 FBP8 clinical trials
How each study uses Copper Cu 64 FBP8 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Copper Cu 64 FBP8 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- 64Cu-FBP8
- 3
Studies by the year they started
3 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Massachusetts General Hospital (2) · Peter Caravan (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Copper Cu 64 FBP8.
- Jan 2027Positron Emission Tomography (PET) Imaging of ThrombosisPhase 1 · Massachusetts General Hospital
Studies
Open first, then newest update. How each study uses Copper Cu 64 FBP8 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Positron Emission Tomography (PET) Imaging of ThrombosisRecruitingPhase 1Massachusetts General HospitalNCT03830320Written as [64Cu]FBP8How we know
- Assess Fibrin in Brains With AD/ADRDRecruitingPhase 1/2Massachusetts General HospitalNCT05336695Written as 64Cu-FBP8How we know
- PET Fibrin Imaging of DVT and PETerminatedPhase 1Peter CaravanNCT04022915Written as 64Cu-FBP8How we know